Multiple NADPH-cytochrome P450 reductases from Trypanosoma cruzi. Suggested role on drug resistance

Molecular and Biochemical Parasitology

Volumn 160, Issue 1, 2008, Pages 42-51

  Portal, Patricio ^a   Villamil, Silvia Fernández ^a   Alonso, Guillermo D ^a   De Vas, Matias G ^a   Flawiá, Mirtha M ^a   Torres, Héctor N ^a   Paveto, Cristina ^a  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

Author keywords

Cytochrome P450 reductase; Drug resistance; Trypanosoma cruzi

Indexed keywords

AMINO ACID; BENZNIDAZOLE; CYTOCHROME C; CYTOCHROME P450; DIPHENYLIODONIUM SALT; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; NIFURTIMOX; POLYCLONAL ANTISERUM; PROTEIN; RECOMBINANT ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CELL CULTURE; CLONE; DEVELOPMENTAL STAGE; EPIMASTIGOTE; ESCHERICHIA COLI; GENE SEQUENCE; MICROSOME; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

AMINO ACID SEQUENCE; ANIMALS; DNA, PROTOZOAN; DRUG RESISTANCE; ESCHERICHIA COLI; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; NADPH-FERRIHEMOPROTEIN REDUCTASE; RATS; RECOMBINANT PROTEINS; TRANSFECTION; TRYPANOSOMA CRUZI;

ESCHERICHIA COLI; RATTUS; TRYPANOSOMA CRUZI;

EID: 43949098939     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2008.03.007     Document Type: Article

References (43)

1. Gibson G.S.P. Introduction to Drug Metabolism (2001), Bath, UK
2. Murataliev M.B., Feyereisen R., and Walker F.A. Electron transfer by diflavin reductases. Biochim Biophys Acta 1698 (2004) 1-26
3. Ostrowski J., Barber M.J., Rueger D.C., Miller B.E., Siegel L.M., and Kredich N.M. Characterization of the flavoprotein moieties of NADPH-sulfite reductase from Salmonella typhimurium and Escherichia coli. Physicochemical and catalytic properties, amino acid sequence deduced from DNA sequence of cysJ, and comparison with NADPH-cytochrome P-450 reductase. J Biol Chem 264 (1989) 15796-15808
4. Iyanagi T. Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain. Biochem Biophys Res Commun 338 (2005) 520-528
5. Masters B.S. The journey from NADPH-cytochrome P450 oxidoreductase to nitric oxide synthases. Biochem Biophys Res Commun 338 (2005) 507-519
6. Nelson D.R., Koymans L., Kamataki T., et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6 (1996) 1-42
7. Guengerich F.P. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol Lett 70 (1994) 133-138
8. Cheng J., Wan D.F., Gu J.R., et al. Establishment of a yeast system that stably expresses human cytochrome P450 reductase: application for the study of drug metabolism of cytochrome P450s in vitro. Protein Expr Purif 47 (2006) 467-476
9. Louerat-Oriou B., Perret A., and Pompon D. Differential redox and electron-transfer properties of purified yeast, plant and human NADPH-cytochrome P-450 reductases highly modulate cytochrome P-450 activities. Eur J Biochem 258 (1998) 1040-1049
10. Koopmann E., and Hahlbrock K. Differentially regulated NADPH:cytochrome P450 oxidoreductases in parsley. Proc Natl Acad Sci USA 94 (1997) 14954-14959
11. Ro D.K., Ehlting J., and Douglas C.J. Cloning, functional expression, and subcellular localization of multiple NADPH-cytochrome P450 reductases from hybrid poplar. Plant Physiol 130 (2002) 1837-1851
12. Porter T.D., Beck T.W., and Kasper C.B. NADPH-cytochrome P-450 oxidoreductase gene organization correlates with structural domains of the protein. Biochemistry 29 (1990) 9814-9818
13. Paine M.J., Garner A.P., Powell D., et al. Cloning and characterization of a novel human dual flavin reductase. J Biol Chem 275 (2000) 1471-1478
14. Kwasnicka-Crawford D.A., and Vincent S.R. Role of a novel dual flavin reductase (NR1) and an associated histidine triad protein (DCS-1) in menadione-induced cytotoxicity. Biochem Biophys Res Commun 336 (2005) 565-571
15. Agosin M., Naquira C., Paulin J., and Capdevila J. Cytochrome P-450 and drug metabolism in Trypanosoma cruzi: effects of phenobarbital. Science 194 (1976) 195-197
16. Kuwahara T., White Jr. R.A., and Agosin M. A cytosolic FAD-containing enzyme catalyzing cytochrome c reduction in Trypanosoma cruzi. I. Purification and some properties. Arch Biochem Biophys 239 (1985) 18-28
17. Berger B.J., and Fairlamb A.H. Cytochrome P450 in trypanosomatids. Biochem Pharmacol 46 (1993) 149-157
18. Lepesheva G.I., Zaitseva N.G., Nes W.D., et al. CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B' helix defines substrate preferences of sterol 14alpha-demethylase. J Biol Chem 281 (2006) 3577-3585
19. Buckner F.S., Joubert B.M., Boyle S.M., Eastman R.T., Verlinde C.L., and Matsuda S.P. Cloning and analysis of Trypanosoma cruzi lanosterol 14alpha-demethylase. Mol Biochem Parasitol 132 (2003) 75-81
20. Braga M.V., Urbina J.A., and de Souza W. Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents 24 (2004) 72-78
21. Garzoni L.R., Caldera A., Meirelles Mde N., et al. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. Int J Antimicrob Agents 23 (2004) 273-285
22. Hankins E.G., Gillespie J.R., Aikenhead K., and Buckner F.S. Upregulation of sterol C14-demethylase expression in Trypanosoma cruzi treated with sterol biosynthesis inhibitors. Mol Biochem Parasitol 144 (2005) 68-75
23. Docampo R. Sensitivity of parasites to free radical damage by antiparasitic drugs. Chem Biol Interact 73 (1990) 1-27
24. Igoillo-Esteve M., and Cazzulo J.J. The glucose-6-phosphate dehydrogenase from Trypanosoma cruzi: its role in the defense of the parasite against oxidative stress. Mol Biochem Parasitol 149 (2006) 170-181
25. Pereira C.A., Alonso G.D., Paveto M.C., et al. Trypanosoma cruzi arginine kinase characterization and cloning. A novel energetic pathway in protozoan parasites. J Biol Chem 275 (2000) 1495-1501
26. Lorenzi H.A., Vazquez M.P., and Levin M.J. Integration of expression vectors into the ribosomal locus of Trypanosoma cruzi. Gene 310 (2003) 91-99
27. Previato J.O., Sola-Penna M., Agrellos O.A., et al. Biosynthesis of O-N-acetylglucosamine-linked glycans in Trypanosoma cruzi Characterization of the novel uridine diphospho-N-acetylglucosamine:polypeptide. N-acetylglucosaminyltransferase-catalyzing formation of N-acetylglucosamine alpha1-->O-threonine. J Biol Chem 273 (1998) 14982-14988
28. Kuwahara T., White Jr. R.A., and Agosin M. A cytosolic flavin-containing enzyme catalyzing reduction of cytochrome c in Trypanosoma cruzi: kinetic studies with cytochrome c as substrate. Arch Biochem Biophys 241 (1985) 45-49
29. Dubin M., Fernandez Villamil S.H., and Stoppani A.O. Inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions by beta-lapachone and related naphthoquinones. Biochem Pharmacol 39 (1990) 1151-1160
30. Mazel P. Experiments illustrating drug metabolism in vitro. In: LaDu B.N., Mandel H., and Way E. (Eds). Fundamentals of drug metabolism and drug disposition (1971), William and Wilkins, Baltimore 546-556
31. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
33. Michels P.A., Marchand M., Kohl L., Allert S., Wierenga R.K., and Opperdoes F.R. The cytosolic and glycosomal isoenzymes of glyceraldehyde-3-phosphate dehydrogenase in Trypanosoma brucei have a distant evolutionary relationship. Eur J Biochem 198 (1991) 421-428
34. Keyes S.R., Fracasso P.M., Heimbrook D.C., Rockwell S., Sligar S.G., and Sartorelli A.C. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Cancer Res 44 (1984) 5638-5643
35. Shen A.L., and Kasper C.B. Role of acidic residues in the interaction of NADPH-cytochrome P450 oxidoreductase with cytochrome P450 and cytochrome c. J Biol Chem 270 (1995) 27475-27480
36. Durst F., and Nelson D.R. Diversity and evolution of plant P450 and P450-reductases. Drug Metabol Drug Interact 12 (1995) 189-206
37. Fuziwara S., Sagami I., Rozhkova E., et al. Catalytically functional flavocytochrome c himeras of P450 BM3 and nitric oxide synthase. J Inorg Biochem 91 (2002) 515-526
38. Walton M.I., Wolf C.R., and Workman P. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1 4-dioxide (SR 4233, WIN 59075) by mouse liver. Biochem Pharmacol 44 (1992) 251-259
39. Wilkinson S.R., and Kelly J.M. The role of glutathione peroxidases in trypanosomatids. Biol Chem 384 (2003) 517-525
40. Maya J.D., Repetto Y., Agosin M., et al. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi. Mol Biochem Parasitol 86 (1997) 101-106
41. Murta S.M., Krieger M.A., Montenegro L.R., et al. Deletion of copies of the gene encoding old yellow enzyme (TcOYE), a NAD(P)H flavin oxidoreductase, associates with in vitro-induced benznidazole resistance in Trypanosoma cruzi. Mol Biochem Parasitol 146 (2006) 151-162
42. Buckner F.S., Wilson A.J., White T.C., and Van Voorhis W.C. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrob Agents Chemother 42 (1998) 3245-3250
43. Biagiotti E., Ferri P., Dringen R., Del Grande P., and Ninfali P. Glucose-6-phosphate dehydrogenase and NADPH-consuming enzymes in the rat olfactory bulb. J Neurosci Res 80 (2005) 434-441